Adjunctive treatment for pediatric focal epilepsy: a systematic review
European Journal of Clinical Pharmacology · 2025-04 · 81 (4) · 507-523
DOI: 10.1007/s00228-025-03807-9 ↗Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 13.02.2025. Verfasst von Siru Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, Shandong Province, China. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsies, Partial. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: the Women and Children Health Care Association of Shandong, the Shandong Provincial Center for ADR Monitoring, China.
Abstract (Originalsprache)
PURPOSE: We aim to use a network meta-analysis to evaluate the efficacy and safety of antiseizure medications and provide a theoretical basis for rational drug use for children and adolescents in adjunctive treatment. METHODS: The databases of PubMed, Embase, Cochrane Library, and Web of Science were systematically searched for random clinical trials about perampanel, valproic acid, carbamazepine, lacosamide, lamotrigine, levetiracetam, oxcarbazepine, topiramate, zonisamide, brivaracetam, cenobamate, eslicarbazepine acetate, and pregabalin from their inception until December 10, 2023. The included studies' risk of bias was evaluated by the Cochrane Collaboration's tool (RoB2). The network meta-analysis was performed using Stata 15 on the included studies. RESULTS: Seventeen studies were identified and of these 19 randomized controlled trials evaluating 9 different antiepileptic drugs were included. In total, 2959 patients were covered in the analysis of the outcomes. For efficacy, lacosamide (OR = 1.91, 95%CI 1.14-3.20), lamotrigine (OR = 3.82, 95%CI 1.86-7.83), levetiracetam (OR = 3.01, 95%CI 1.89-4.80), oxcarbazepine (OR = 2.75, 95%CI 1.52-4.96), perampanel (OR = 2.05, 95%CI 1.15-3.65), and zonisamide (OR = 2.27, 95%CI 1.21-4.24) were more effective than placebo in the 50% responder rate. Lamotrigine ranked first on the cumulative probability curve, followed by levetiracetam. Eslicarbazepine acetate (OR = 6.44, 95%CI 1.43-29.00) and levetiracetam (OR = 5.75, 95%CI 2.45-13.50) were better than placebo in seizure freedom. For safety, topiramate (OR = 4.11, 95%CI 1.43-11.76) and oxcarbazepine (OR = 2.72, 1.28-5.76) were more likely to cause adverse effects in children or adolescents compared to placebo. CONCLUSION: In terms of efficacy and safety, lamotrigine and levetiracetam may be selected preferentially for the adjunctive treatment of focal epilepsy in children and adolescents. However, owing to the limited random clinical trials, our results need to be verified by further studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, Shandong Province, China.
- Affiliated Hospital of Shandong Academy of Traditional Chinese Medicine, Jinan, 250014, Shandong Province, China.
- Shandong Provincial Center for ADR Monitoring, Jinan, 250014, Shandong Province, China.
- Department of Pharmacy, Qingdao Women and Children's Hospital, Qingdao, 266034, Shandong Province, China. lch1001@yeah.net.
Förderung
- the Women and Children Health Care Association of Shandong
- the Shandong Provincial Center for ADR Monitoring, China
Zitieren
APA
Wang, S., Sun, H., Wang, Z., Sun, C., Zhang, X., & Liu, C. (2025). Adjunctive treatment for pediatric focal epilepsy: a systematic review. European Journal of Clinical Pharmacology, 81(4), 507-523. https://doi.org/10.1007/s00228-025-03807-9
Vancouver
Wang S, Sun H, Wang Z, Sun C, Zhang X, Liu C. Adjunctive treatment for pediatric focal epilepsy: a systematic review. European Journal of Clinical Pharmacology. 2025;81(4):507-523. doi:10.1007/s00228-025-03807-9
BibTeX
@article{Wang2025,
author = {Wang, Siru and Sun, Hu and Wang, Zhaoxuan and Sun, Chunxiao and Zhang, Xiaolu and Liu, Chang},
title = {Adjunctive treatment for pediatric focal epilepsy: a systematic review},
journal = {European Journal of Clinical Pharmacology},
year = {2025},
volume = {81},
number = {4},
pages = {507--523},
doi = {10.1007/s00228-025-03807-9}
}
EUVIMED